V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220006067 | 220002363 | 1.78 | 35.3 | Disease modification (D) | 2013-06-22 | 2013-06-29 | DAUNORUBICIN + METHOTREXATE + RITUXIMAB + VINCRISTINE | N | N | 220029559 | NOT MATCHED |
| 220006068 | 220002363 | null | null | null | null | 2016-11-01 | Nilotinib | N | N | 220029559 | NILOTINIB |
| 220006069 | 220002364 | null | 0 | null | 2013-10-05 | 2013-10-05 | Nilotinib | N | N | 220029566 | NILOTINIB |
| 220006070 | 220002365 | 1.65 | null | Curative (C) | 2014-03-19 | 2014-03-19 | AML 19 TRIAL | Y | N | 220029567 | AML19 TRIAL |
| 220006071 | 220002365 | null | 65.8 | Curative (C) | 2013-01-03 | 2013-01-06 | AML 19 TRIAL | 1 | N | 220029567 | AML19 TRIAL |
| 220006072 | 220002365 | null | 17.6 | Curative (C) | 2013-04-08 | 2013-07-17 | null | N | N | 220029567 | NOT MATCHED |
| 220006073 | 220002365 | 1.85 | 80 | Disease modification (D) | 2014-03-14 | 2014-03-14 | Nilotinib | N | N | 220029567 | NILOTINIB |
| 220006074 | 220002365 | null | 100 | Adjuvant (A) | 2017-07-20 | 2017-07-20 | FLAG + Idarubicin | 02 | null | 220029567 | FLAG + IDARUBICIN |
| 220006075 | 220021235 | null | 17 | Curative (C) | 2015-03-16 | 2015-06-12 | null | Y | N | 220029572 | NOT MATCHED |
| 220006076 | 220021235 | 1.6 | null | Adjuvant (A) | 2016-02-20 | 2016-02-20 | Nilotinib | 02 | N | 220029572 | NILOTINIB |
| 220006077 | 220021235 | 1.68 | 93.8 | Curative (C) | 2015-08-25 | 2015-09-01 | FLAG + Idarubicin | 2 | null | 220029572 | FLAG + IDARUBICIN |
| 220006078 | 220021235 | 1.7 | 0 | Not known (9) | 2013-10-29 | 2013-11-09 | Nilotinib | 2 | N | 220029572 | NILOTINIB |
| 220006079 | 220002366 | 1.83 | 71.2 | Disease modification (D) | 2017-09-07 | 2017-09-14 | FLAG + Idarubicin | N | N | 220029580 | FLAG + IDARUBICIN |
| 220006080 | 220002366 | 1.64 | 79.6 | Curative (C) | 2016-07-25 | 2016-10-04 | FLAG + Idarubicin | N | N | 220029580 | FLAG + IDARUBICIN |
| 220006081 | 220016080 | 0 | null | Curative (C) | 2016-04-10 | 2016-04-13 | Nilotinib | 2 | N | 220029583 | NILOTINIB |
| 220006082 | 220016080 | 0.65 | 20.4 | Curative (C) | 2013-06-18 | 2013-06-25 | AML Relapsed High Dose Cytarabine | N | N | 220029583 | NOT MATCHED |
| 220006083 | 220016080 | 1.84 | 45.7 | Curative (C) | 2016-07-11 | 2016-07-11 | AML 19 TRIAL | Y | N | 220029583 | AML19 TRIAL |
| 220006084 | 220016080 | 0 | 0 | Curative (C) | 2016-06-03 | 2016-11-09 | Nilotinib | 2 | N | 220029583 | NILOTINIB |
| 220006085 | 220016080 | 0 | 0 | Curative (C) | 2015-02-11 | 2015-02-11 | Nilotinib | 02 | N | 220029583 | NILOTINIB |
| 220006086 | 220016080 | null | null | Curative (C) | 2017-08-03 | 2017-08-06 | Nilotinib | 02 | N | 220029583 | NILOTINIB |
| 220006087 | 220016080 | 1.74 | null | Curative (C) | 2014-07-12 | 2014-07-12 | Nilotinib | N | N | 220029583 | NILOTINIB |
| 220006088 | 220002367 | 1.7 | 0 | Curative (C) | 2017-06-20 | 2017-06-20 | Nilotinib | N | N | 220029594 | NILOTINIB |
| 220006089 | 220002367 | 0 | 17.6 | Curative (C) | 2015-10-07 | 2015-10-07 | null | N | N | 220029594 | NOT MATCHED |
| 220006090 | 220002367 | 1.72 | 96.4 | Disease modification (D) | 2014-05-14 | 2014-05-15 | FLAG + Idarubicin | null | null | 220029594 | FLAG + IDARUBICIN |
| 220006091 | 220002368 | 1.71 | 54.8 | Curative (C) | 2015-10-22 | 2015-10-23 | FLAG + Idarubicin | 02 | N | 220029599 | FLAG + IDARUBICIN |
| 220006092 | 220002369 | 1.78 | 90.2 | Curative (C) | 2017-04-08 | 2017-04-08 | AML 19 TRIAL | Y | null | 220029602 | AML19 TRIAL |
| 220006093 | 220002369 | 1.55 | 101 | Curative (C) | 2015-01-13 | 2015-01-13 | FLAG + Idarubicin | N | N | 220029602 | FLAG + IDARUBICIN |
| 220006094 | 220002369 | 1.68 | 57 | Curative (C) | 2013-10-16 | 2013-10-16 | AML 19 TRIAL | 1 | N | 220029602 | AML19 TRIAL |
| 220006095 | 220002369 | 1.79 | null | Curative (C) | 2014-03-06 | 2014-03-06 | AML 19 TRIAL | Y | N | 220029602 | AML19 TRIAL |
| 220006096 | 220002370 | null | 0 | Disease modification (D) | 2017-06-16 | 2017-06-16 | Nilotinib | 02 | N | 220029608 | NILOTINIB |
| 220006097 | 220002370 | 1.71 | 89.4 | Curative (C) | 2015-12-08 | 2015-12-19 | AML 19 TRIAL | Y | N | 220029608 | AML19 TRIAL |
| 220006098 | 220002370 | null | 82 | Curative (C) | 2015-02-18 | 2015-02-19 | AML 19 TRIAL | Y | N | 220029608 | AML19 TRIAL |
| 220006099 | 220002370 | 1.76 | 68.6 | Curative (C) | 2018-01-05 | 2018-01-06 | FLAG + Idarubicin | Y | N | 220029608 | FLAG + IDARUBICIN |
| 220006100 | 220002370 | null | null | null | 2013-02-19 | 2014-08-23 | Nilotinib | N | N | 220029608 | NILOTINIB |
| 220006101 | 220021237 | 1.72 | 85.4 | Curative (C) | 2015-12-08 | 2015-12-16 | FLAG + Idarubicin | 01 | N | 220029616 | FLAG + IDARUBICIN |
| 220006102 | 220002371 | 1.76 | 80 | Curative (C) | 2015-10-25 | 2015-10-25 | AML 19 TRIAL | 1 | N | 220029621 | AML19 TRIAL |
| 220006103 | 220002371 | 1.88 | null | Curative (C) | 2018-03-14 | 2018-03-14 | Nilotinib | N | N | 220029621 | NILOTINIB |
| 220006104 | 220002372 | 0 | 0 | Curative (C) | null | 2015-01-07 | Nilotinib | 02 | N | 220029626 | NILOTINIB |
| 220006105 | 220002372 | null | 52.6 | Curative (C) | 2017-06-15 | 2017-07-08 | AML MyeChild 01 Triple IT | N | N | 220029626 | NOT MATCHED |
| 220006106 | 220002373 | null | null | Palliative (P) | 2017-02-02 | 2017-02-09 | null | N | N | 220029629 | NOT MATCHED |
| 220006107 | 220002374 | 1.63 | 66.2 | Curative (C) | 2017-04-29 | 2017-04-30 | FLAG + Idarubicin | null | null | 220029630 | FLAG + IDARUBICIN |
| 220006108 | 220002374 | null | 0 | Radical (R) | 2016-11-23 | 2016-12-07 | Nilotinib | null | null | 220029630 | NILOTINIB |
| 220006109 | 220002375 | 1.66 | 83 | Curative (C) | 2016-03-26 | 2016-03-27 | AML 19 TRIAL | 01 | N | 220029633 | AML19 TRIAL |
| 220006110 | 220002376 | null | 8.4 | Curative (C) | 2015-04-18 | 2015-04-21 | null | Y | N | 220029635 | NOT MATCHED |
| 220006111 | 220002376 | 1.63 | 63.2 | Curative (C) | 2014-09-20 | 2014-09-20 | AML 19 TRIAL | N | N | 220029635 | AML19 TRIAL |
| 220006112 | 220002377 | null | 64 | Disease modification (D) | 2015-01-05 | 2015-01-12 | Nilotinib | N | N | 220029637 | NILOTINIB |
| 220006113 | 220011335 | 1.74 | 98.5 | Palliative (P) | 2016-10-11 | 2016-10-11 | Nilotinib | N | N | 220029638 | NILOTINIB |
| 220006114 | 220011335 | 1.66 | 53.15 | Curative (C) | 2014-08-05 | 2014-08-05 | AML 19 TRIAL | Y | null | 220029638 | AML19 TRIAL |
| 220006115 | 220018800 | null | null | Palliative (P) | 2014-02-13 | 2014-02-14 | Nilotinib | N | N | 220029646 | NILOTINIB |
| 220006116 | 220018800 | 0 | 48.6 | Curative (C) | 2017-09-15 | 2017-09-17 | Nilotinib | N | N | 220029646 | NILOTINIB |